Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.53 +0.20 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Return on Capital Employed [ROCE] was 6.60% in Q2 2026, up 3.33 percentage points from 3.26% a year earlier but down 1.93 percentage points from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Teva Pharmaceutical Industries came in at 8.11%, up 9.17 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +16.85 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -1.06% in FY2024 (-2.43 pp), 1.37% in FY2023 (+7.77 pp), -6.39% in FY2022 (-10.89 pp) and 4.50% in FY2021 (+13.24 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -6.72% (Q4 2022) and 8.52% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for six straight quarters, with an average year-over-year change of +3.55 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2021 (a gain of 15.09 percentage points); the worst was Q4 2022 (a drop of 11.40 percentage points).
  • Per Business Quant data, TEVA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 8.52% (Q1 2026), 8.03% (Q4 2025) and 6.41% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Teva Pharmaceutical Industries 45.83 Bn 32.68 Bn 2.15 Bn 6.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.60%
Mar 31, 2026 8.52%
Dec 31, 2025 8.03%
Sep 30, 2025 6.41%
Jun 30, 2025 3.26%
Mar 31, 2025 1.57%
Dec 31, 2024 -1.09%
Sep 30, 2024 1.74%
Jun 30, 2024 3.02%
Mar 31, 2024 0.78%
Dec 31, 2023 1.42%
Sep 30, 2023 -4.05%
Jun 30, 2023 -3.76%
Mar 31, 2023 -4.49%
Dec 31, 2022 -6.72%
Sep 30, 2022 -3.51%
Jun 30, 2022 -2.76%
Mar 31, 2022 1.59%
Dec 31, 2021 4.67%
Sep 30, 2021 5.57%
API Access

Teva Pharmaceutical Industries Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEY